Русские видео

Сейчас в тренде

Иностранные видео


Скачать с ютуб Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery в хорошем качестве

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery 8 лет назад


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса savevideohd.ru



Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

Prof Neoptolemos meets with ecancertv at ASCO 2016 to discuss ESPAC-4, an international phase III trial of gemcitabine and capecitabine in combination, or as mono therapy, for patients with resected pancreatic ductal adenocarcinoma. With 732 patients, the European Study Group for Pancreatic Cancer (ESPAC) 4 trial is the second-largest clinical trial ever conducted in patients with pancreatic cancer who had undergone surgery. The median overall survival was 28.0 months with the combination regimen vs. 25.5 months with gemcitabine alone, and the estimated 5-year survival rates were 28.8% vs. 16.3% in the two groups.

Comments